Klopidogrel Pharmas (Clopidogrel)

Clopidogrel irreversibly blocks the platelet P2Y12 ADP receptor, which is essential for ADP‑mediated platelet activation and aggregation. By inhibiting this pathway, the drug reduces the ability of platelets to clump together, thereby lowering the likelihood of arterial thrombus formation that can lead to heart attacks, strokes, or limb‑ischaemia.

The dosage of Klopidogrel Pharmas is determined by the prescribing healthcare professional based on the patient’s specific clinical situation, renal and hepatic function, and concomitant medications. Patients should follow the exact regimen provided by their physician and not adjust the dose on their own.

The safety of clopidogrel in pregnancy and lactation has not been definitively established, and it is classified as having an unknown pregnancy category. Healthcare providers will weigh potential benefits against possible risks before prescribing it to pregnant or nursing mothers, and alternative therapies may be considered when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Clopidogrel belongs to the thienopyridine class and is a P2Y12 receptor antagonist, similar to ticagrelor and prasugrel. Compared with aspirin, clopidogrel provides more potent inhibition of platelet aggregation without affecting cyclo‑oxygenase pathways. Relative to newer agents, clopidogrel has a longer track record, a once‑daily dosing schedule, and a lower cost, but its activation depends on CYP2C19 metabolism, which can affect efficacy in certain patients.

Store Klopidogrel Pharmas at room temperature, preferably below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture, excessive heat, and direct sunlight to maintain stability and potency throughout the shelf life.

Klopidogrel Pharmas is taken orally, usually with a glass of water. The tablet should be swallowed whole and can be taken with or without food, unless the prescribing physician advises otherwise. Patients should not crush, chew, or split the tablet unless instructed to do so.

The most serious risks include severe or life‑threatening bleeding such as intracranial hemorrhage, gastrointestinal bleeding, and bleeding that requires transfusion or surgery. Rare but critical reactions can involve thrombocytopenia, allergic anaphylaxis, and thrombotic thrombocytopenic purpura. Patients should seek immediate medical attention if they experience unusual bruising, blood in stool or urine, or signs of an allergic reaction.

Clopidogrel is contraindicated in individuals with active pathological bleeding, known hypersensitivity to clopidogrel or any component of the formulation, and patients with severe hepatic impairment. Caution is also advised for those with a history of hemorrhagic stroke, uncontrolled hypertension, or concurrent use of strong anticoagulants without appropriate medical supervision.